StockWatch
·
Biotechnology: Laboratory Analytical Instruments
Quarterly ResultJul 29, 2026, 09:07 AM

Avantor Q2 Net Income $38.1M, EPS $0.06; Sales Up Slightly

AI Summary

Avantor reported Q2 2026 net sales of $1,692.3 million, a slight increase from the prior year, but net income significantly decreased to $38.1 million, resulting in diluted EPS of $0.06. For the first half of 2026, net income was $81.4 million, down from $129.2 million in H1 2025. The company also disclosed ongoing securities class action and shareholder derivative lawsuits, which it intends to vigorously defend, and noted a goodwill impairment assessment was triggered in Q1 2026 due to market conditions, though no impairment was recorded.

Key Highlights

  • Q2 2026 Net Sales: $1,692.3M, up from $1,683.4M in Q2 2025.
  • Q2 2026 Net Income: $38.1M, down from $64.7M in Q2 2025.
  • Q2 2026 Diluted EPS: $0.06, down from $0.09 in Q2 2025.
  • H1 2026 Net Cash from Operating Activities: $236.9M, down from $263.7M.
  • H1 2026 Debt Repayments: $217.5M, significantly up from $38.1M.
  • Segment reorganization effective Jan 1, 2026, into two new segments.
  • Securities class action and shareholder derivative lawsuits are ongoing.
  • Goodwill impairment assessment triggered in Q1 2026, no impairment recorded.